Member login

By using the members area you have already agreed to share your personal information with the BGMA/BBA so that you can access the members materials. We will store your details only as long as you are a member. Your personal information will not be shared any affiliated companies or third parties. For more information about our Privacy Policy, click here.

Cookie Policy

We use cookies on our website to ensure that we give you the best experience we can. If you continue to use our site without changing your settings, we'll assume that you are happy for us to use cookies. More information can be found in our Privacy Policy.

BGMA reaction to Government letter on no-deal Brexit preparations

Warwick Smith, Director General of the British Generic Manufacturers Association (BGMA), said: “We welcome the fact that the Government is working with industry to secure the supply of medicines to patients in the case of a no-deal Brexit. Our members have cooperated with the Government’s request for holding additional stocks and providing data to allow them to assess the risk to the supply of medicines, and to work with us on putting in place mitigating measures.

“However, whilst the outcome of Brexit clearly remains uncertain, it is now the time to accelerate this work and putting mitigating measures in place takes time. Therefore, while an update from the Secretary of State is helpful, it contains less detailed information than leaks from other Government Departments. It is vitally important that the Government shares with us and others all their current information so that we can plan accordingly.”